A news article in Pain Research Forum covering proceedings at the 15th World Congress on Pain examines the clinical management of neuropathic pain, including a presentation on proposed new guidelines for the treatment of neuropathic pain. The paper additionally previewed a future where neuropathic pain patients will no longer be lumped together by etiology and treated for generic pain, but rather will be sorted by transetiological symptoms or signs and treated with rational therapies based on the underlying mechanisms of pain.
Over the years, several clinical guidelines have been produced based on systematic reviews and meta-analyses of existing clinical trials for the various medications used in the treatment of neuropathic pain. These primarily include antidepressants, antiepileptics, some opioids, and topical preparations. The author contends that an update is now in order, as the most recent guidelines are 4 or more years old. Since then, there have been several large trials, new treatments, and advances in techniques for evaluating evidence.
Read the complete article, with links to source materials, here.